Strength exercise for balance and gait in HIV-associated distal symmetrical polyneuropathy: A randomised controlled trial

被引:0
|
作者
Yakasai, Abdulsalam M. [1 ,2 ]
Maharaj, Sonill [1 ]
Danazumi, Musa S. [3 ,4 ]
机构
[1] Univ KwaZulu Natal, Dept Physiotherapy, Fac Hlth Sci, Durban, South Africa
[2] Kano Zonal Off, Med Rehabil Therapists Board, Kano, Nigeria
[3] Bayero Univ, Fac Allied Hlth Sci, Dept Physiotherapy, Kano, Nigeria
[4] Fed Med Ctr, Dept Physiotherapy, Nguru, Yobe State, Nigeria
关键词
HIV-associated neuropathy; balance; gait; strength training; outcomes; rehabilitation; antiretroviral therapy; QUALITY-OF-LIFE; PERIPHERAL NEUROPATHY; PEOPLE; PAIN; INTERVENTION; EPIDEMIOLOGY; OUTCOMES; FALL; RISK;
D O I
10.4102/sajhivmed.v22i1.1268
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: HIV-associated peripheral neuropathy (PN) is a common neurological complication associated with HIV infection. Distal symmetrical polyneuropathy (DSPN) is the most commonly occurring type, which is associated with symptoms such as numbness, unsteady gait and, in some cases, muscle atrophy and weakness when myelinated nerve fibres are affected. If unmyelinated nerve fibres are affected, a painful neuropathy and autonomic symptoms may occur. Objectives: This research study assessed the effects of a strength exercise intervention on balance impairment and gait disturbance amongst individuals living with HIV-associated DSPN. Method: The study was a single-blinded, randomised controlled trial (RCT) with participants sourced from four HIV centres in Kano metropolis, Nigeria. The intervention was supervised and included progressive resistance exercise (PRE) (three 40-min sessions per week for 12 weeks) using a quadriceps bench (n = 44). The control group (CG) included the non-exercise group (n = 47). The two groups continued to receive routine care. Data were summarised and analysed using inferential statistics (SPSS version 20 program) with the alpha level set at < 0.05. Results: At 12 weeks, the results revealed significant improvement with regard to balance performance (p = 0.001) and walking ability (p = 0.001) in the training group. In contrast, no significant differences in balance (P = 0.677) or gait (P = 0.578) were observed in the CG. Conclusion: The findings suggest that PRE is beneficial for balance impairment and gait disturbance caused by neuropathy in persons living with HIV and receiving antiretroviral drugs.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Screening for HIV-associated distal-symmetric polyneuropathy in CDC-classification stages 1, 2 and 3
    Husstedt, IW
    Evers, S
    Reichelt, D
    Grotemeyer, KH
    Kammer-Suhr, B
    Böckenholt, S
    Heese, C
    ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (03): : 183 - 187
  • [32] NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-associated Distal Sensory Polyneuropathy
    Simpson, David M.
    Brown, Stephen
    Tobias, Jeffrey K.
    Vanhove, Geertrui F.
    CLINICAL JOURNAL OF PAIN, 2014, 30 (02): : 134 - 142
  • [33] A randomised controlled trial among cleaners-Effects on strength, balance and kinesiophobia
    Marie Birk Jørgensen
    John Ektor-Andersen
    Gisela Sjøgaard
    Andreas Holtermann
    Karen Søgaard
    BMC Public Health, 11
  • [34] A randomised controlled trial among cleaners-Effects on strength, balance and kinesiophobia
    Jorgensen, Marie Birk
    Ektor-Andersen, John
    Sjogaard, Gisela
    Holtermann, Andreas
    Sogaard, Karen
    BMC PUBLIC HEALTH, 2011, 11
  • [36] The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis
    Lawrence, David S.
    Tsholo, Katlego
    Ssali, Agnes
    Mupambireyi, Zivai
    Hoddinott, Graeme
    Nyirenda, Deborah
    Meya, David B.
    Ndhlovu, Chiratidzo
    Harrison, Thomas S.
    Jarvis, Joseph N.
    Seeley, Janet
    BMJ OPEN, 2021, 11 (04):
  • [37] Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial
    Carmen Gonzalez-Martinez
    Katharina Kranzer
    Grace McHugh
    Elizabeth L. Corbett
    Hilda Mujuru
    Mark P. Nicol
    Sarah Rowland-Jones
    Andrea M. Rehman
    Tore J. Gutteberg
    Trond Flaegstad
    Jon O. Odland
    Rashida A. Ferrand
    Trials, 18
  • [38] Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial
    Gonzalez-Martinez, Carmen
    Kranzer, Katharina
    McHugh, Grace
    Corbett, Elizabeth L.
    Mujuru, Hilda
    Nicol, Mark P.
    Rowland-Jones, Sarah
    Rehman, Andrea M.
    Gutteberg, Tore J.
    Flaegstad, Trond
    Odland, Jon O.
    Ferrand, Rashida A.
    TRIALS, 2017, 18
  • [39] Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial
    Namale, Phiona E.
    Boloko, Linda
    Vermeulen, Marcia
    Haigh, Kate A.
    Bagula, Fortuna
    Maseko, Alexis
    Sossen, Bianca
    Lee-Jones, Scott
    Msomi, Yoliswa
    McIlleron, Helen
    Mnguni, Ayanda Trevor
    Crede, Thomas
    Szymanski, Patryk
    Naude, Jonathan
    Ebrahim, Sakeena
    Vallie, Yakoob
    Moosa, Muhammed Shiraz
    Bandeker, Ismail
    Hoosain, Shakeel
    Nicol, Mark P.
    Samodien, Nazlee
    Centner, Chad
    Dowling, Wentzel
    Denti, Paolo
    Gumedze, Freedom
    Little, Francesca
    Parker, Arifa
    Price, Brendon
    Schietekat, Denzil
    Simmons, Bryony
    Hill, Andrew
    Wilkinson, Robert J.
    Oliphant, Ida
    Hlungulu, Siphokazi
    Apolisi, Ivy
    Toleni, Monica
    Asare, Zimkhitha
    Mpalali, Mkanyiseli Kenneth
    Boshoff, Erica
    Prinsloo, Denise
    Lakay, Francisco
    Bekiswa, Abulele
    Jackson, Amanda
    Barnes, Ashleigh
    Johnson, Ryan
    Wasserman, Sean
    Maartens, Gary
    Barr, David
    Schutz, Charlotte
    Meintjes, Graeme
    TRIALS, 2024, 25 (01)
  • [40] Lamotrigine for HIV-associated painful sensory neuropathies - A placebo-controlled trial
    Simpson, DM
    McArthur, JC
    Olney, R
    Clifford, D
    So, Y
    Ross, D
    Baird, BJ
    Barrett, P
    Hammer, AE
    NEUROLOGY, 2003, 60 (09) : 1508 - 1514